These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17313198)

  • 1. Role of mitochondrial dysfunction in Parkinson's disease: Implications for treatment.
    Ramsey CP; Giasson BI
    Drugs Aging; 2007; 24(2):95-105. PubMed ID: 17313198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
    Zuo L; Motherwell MS
    Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of sporadic Parkinson's disease: contribution of genetic and environmental risk factors].
    Takahashi R; Kawamata J; Takeuchi H
    Rinsho Shinkeigaku; 2009 Nov; 49(11):885-7. PubMed ID: 20030238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease and age: The obvious but largely unexplored link.
    Abdullah R; Basak I; Patil KS; Alves G; Larsen JP; Møller SG
    Exp Gerontol; 2015 Aug; 68():33-8. PubMed ID: 25261764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
    Ebadi M; Govitrapong P; Sharma S; Muralikrishnan D; Shavali S; Pellett L; Schafer R; Albano C; Eken J
    Biol Signals Recept; 2001; 10(3-4):224-53. PubMed ID: 11351130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mitochondrial dysfunction and oxidative damages in the molecular pathology of Parkinson's disease].
    Shadrina MI; Slominskiĭ PA
    Mol Biol (Mosk); 2008; 42(5):809-19. PubMed ID: 18988530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Parkinson's disease-related genes act in mitochondrial homeostasis.
    Sai Y; Zou Z; Peng K; Dong Z
    Neurosci Biobehav Rev; 2012 Oct; 36(9):2034-43. PubMed ID: 22771336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revelations and revolutions in the understanding of Parkinson's disease.
    Dawson TM; Moore DJ; West AB
    Biochim Biophys Acta; 2009 Jul; 1792(7):585-6. PubMed ID: 19539178
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinson's disease.
    Thomas B; Beal MF
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's disease.
    Podlesniy P; Vilas D; Taylor P; Shaw LM; Tolosa E; Trullas R
    Neurobiol Dis; 2016 Oct; 94():10-7. PubMed ID: 27260835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways.
    Soreq L; Ben-Shaul Y; Israel Z; Bergman H; Soreq H
    Neurobiol Dis; 2012 Mar; 45(3):1018-30. PubMed ID: 22198569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of recent genetic findings in Parkinson's disease.
    Klein C; Lohmann-Hedrich K
    Curr Opin Neurol; 2007 Aug; 20(4):453-64. PubMed ID: 17620882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The curious case of phenocopies in families with genetic Parkinson's disease.
    Klein C; Chuang R; Marras C; Lang AE
    Mov Disord; 2011 Aug; 26(10):1793-802. PubMed ID: 21735483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered alpha-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin.
    Singleton AB
    Trends Neurosci; 2005 Aug; 28(8):416-21. PubMed ID: 15955578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial pathology in Parkinson's disease.
    Schapira AH
    Mt Sinai J Med; 2011; 78(6):872-81. PubMed ID: 22069211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine-rich repeat kinase 2: a new player with a familiar theme for Parkinson's disease pathogenesis.
    Li C; Beal MF
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16535-6. PubMed ID: 16275903
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on the genetics of Parkinson's disease.
    Gasser T
    Mov Disord; 2007 Sep; 22 Suppl 17():S343-50. PubMed ID: 18175395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.